News Headlines Article

FDA says providers should avoid compounders that don’t register with feds
Modern Healthcare

The Food and Drug Administration is encouraging healthcare providers to make sure the compounded drugs they buy are mixed in facilities that are registered with the federal agency and are subject to inspections.

A new law that gives the agency more authority over large compounding pharmacies allows the companies to choose whether to register as “outsourcers.” Those that do must provide information about their products, submit to federal inspections and comply with quality standards similar to the ones that apply to drug manufacturers.